Ardian has reinvested in Italian pharmaceutical company Neopharmed in a deal that sees it hold a joint majority stake with NB Renaissance.
Ardian has reinvested in Italian pharmaceutical company Neopharmed in a deal that sees it hold a joint majority stake with NB Renaissance.